Request Your Free White Paper Now:

"Patients, providers and pharma: Working together to address the affordability crisis"

Pharmaceutical companies, providers, and digital platforms can come together to help lower patients’ medication costs and improve health outcomes.

The pandemic and other recent disruptions have highlighted that patient affordability can be complex, and takes unique combinations of people, organizations, technologies, and resources to address. Not all causes of non-adherence can be easily overcome, but patient out-of-pocket (OOP) cost is one for which effective solutions exist today. The affordability crisis is essential to address because cost continues to be a driver of medication non-adherence, and increasing rates of non-adherence compromise overall health outcomes

Pharmaceutical companies, providers, and digital platforms can come together to support a patient’s ability to afford their medication and ultimately improve their adherence to therapies. This executive summary outlines how meaningful provider-patient conversations about the cost of prescribed medications, as well as the awareness and utilization of manufacturer copay programs, can lower patients’ costs and, most importantly, improve their health outcomes.

Offered Free by: GoodRX
See All Resources from: GoodRX